Salud Publica
41.6K views | +0 today
Salud Publica
Que hay en salud? Tendencias y nuevas formas de lograr mejoras sanitarias en las comunidades
Your new post is loading...
Your new post is loading...
Rescooped by Mariano Fernandez S. from Social Media, TIC y Salud!

Do Cancer Patients Tweet? Examining the Twitter Use of Cancer Patients in Japan

Do Cancer Patients Tweet? Examining the Twitter Use of Cancer Patients in Japan | Salud Publica |

ABSTRACTBackground: Twitter is an interactive, real-time media that could prove useful in health care. Tweets from cancer patients could offer insight into the needs of cancer patients.

Objective: The objective of this study was to understand cancer patients’ social media usage and gain insight into patient needs.

Methods: A search was conducted of every publicly available user profile on Twitter in Japan for references to the following: breast cancer, leukemia, colon cancer, rectal cancer, colorectal cancer, uterine cancer, cervical cancer, stomach cancer, lung cancer, and ovarian cancer. We then used an application programming interface and a data mining method to conduct a detailed analysis of the tweets from cancer patients.

Results: Twitter user profiles included references to breast cancer (n=313), leukemia (n=158), uterine or cervical cancer (n=134), lung cancer (n=87), colon cancer (n=64), and stomach cancer (n=44). A co-occurrence network is seen for all of these cancers, and each cancer has a unique network conformation. Keywords included words about diagnosis, symptoms, and treatments for almost all cancers. Words related to social activities were extracted for breast cancer. Words related to vaccination and support from public insurance were extracted for uterine or cervical cancer.

Conclusions: This study demonstrates that cancer patients share information about their underlying disease, including diagnosis, symptoms, and treatments, via Twitter. This information could prove useful to health care providers.

Via Giuseppe Fattori, Celine Sportisse, Lionel Reichardt / le Pharmageek, Usalbiomedica
EmmanuelGrunenberger's curator insight, March 23, 2015 1:11 PM

An example of observing how patients communicate about their diseases using social media... even in Japan.

Kathi Apostolidis's curator insight, March 24, 2015 8:06 AM

Japanese cancer patients or those tweeting in Japanese may share information about their cancer experience on twitter, as is also the case in USA and

Rescooped by Mariano Fernandez S. from Techno World!

Une unique protéine pourrait-elle soigner cancers, Alzheimer et infections ?

Une unique protéine pourrait-elle soigner cancers, Alzheimer et infections ? | Salud Publica |
Un remède miracle ? Des chercheurs américains ont montré qu’une protéine, appelée Tat-bécline 1, stimule un mécanisme cellulaire qui préserverait d’un spectre très large de pathologies, allant des...

Via Gust MEES, Evelyn Izquierdo
Gust MEES's curator insight, February 9, 2013 7:19 AM

À suivre de près...


Rescooped by Mariano Fernandez S. from healthcare technology!

For Some Cancer Patients, Personalized Medicine Has Arrived

For Some Cancer Patients, Personalized Medicine Has Arrived | Salud Publica |

New tools for analyzing genes are allowing doctors to personalize treatment for some lung cancer patients.


Imagine your doctor being able to scan your DNA from a biopsy and pinpoint the medicine that will work best for you. This type of high-tech approach is a clinical reality for advanced lung cancer at The Ohio State Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).


The technology, known as next generation "multiplex" gene sequencing, analyzes 50-plus genes in DNA extracted from a tumor biopsy for particular genetic mutations.


Previous technology required pathologists to analyze one mutation per tube in a sequencing reaction, but next-generation genome sequencing assesses more than 2,500 mutations in a single reaction. 


Knowing which mutations are present in lung tumors can help doctors tailor a patient's treatment to the unique genetic features present in his or her cancer cells.


The knowledge can also help in the development of new drugs that target previously unrecognized gene mutations in lung tumors. I often compare these genes to the gas pedal in a car — when activated, these genes make the cancer grow. By breaking the linkage between the gas pedal and the motor (or interfering with these "driver" mutations) with specific targeted drugs, doctors can stop this growth and often make the cancer shrink.


That's especially important in lung cancer because the majority of patients with this disease are diagnosed in the later stages, meaning it's important to start effective therapies quickly.


For example, a patient could be given a standard chemotherapy and expect a 25- to 30- percent response rate/shrinkage of a tumor. But if the treatment team knows that a patient has a mutation in a gene called EGFR, we can offer him or her a pill (erlotinib and afatinib are approved for this use in the United States), which has a 75-percent response rate and fewer side effects.


Gene sequencing is now considered the standard of care for stage-4 lung cancer patients at The OSUCCC – James and a handful of other centers across the United States — and several clinical trials evaluating molecular targeted therapies for patients with stage-3 lung cancers will soon start at The OSUCCC – James.



Lung cancer remains the number one cause of cancer death in the United States, and in the world, among both men and women. More than 200,000 cases are diagnosed annually in the United States. Each year during the month of November, physicians and others observe lung cancer awareness month, which sheds light on this terrible disease.

Via nrip
No comment yet.